Determine which patients with diabetes require vascular protective therapy
This tool was developed based on the 2018 Diabetes Canada Clinical Practice Guidelines for the Prevention and Management of Diabetes. Published every five years, these guidelines represent the best and most current evidence-based clinical practice data for healthcare professionals.
Diabetes significantly accelerates the development and natural history of cardiovascular disease compared to individuals without diabetes. Healthy behaviour interventions and pharmacological approaches aimed at cardiovascular disease risk reduction can significantly reduce morbidity and mortality, and are an important cornerstone of the management of diabetes.
Stone, J. A., Houlden, R. L., Lin, P., Udell, J. A., Verma, S.
• Angina; previous MI; previous PTCI; previous CABG
• Peripheral artery disease: claudication, peripheral bypass
• Cerebrovascular disease: TIA, CVA
This tool was developed based on the 2018 Diabetes Canada Clinical Practice Guidelines for the Prevention and Management of Diabetes. Published every five years, these guidelines represent the best and most current evidence-based clinical practice data for healthcare professionals.
Diabetes significantly accelerates the development and natural history of cardiovascular disease compared to individuals without diabetes. Healthy behaviour interventions and pharmacological approaches aimed at cardiovascular disease risk reduction can significantly reduce morbidity and mortality, and are an important cornerstone of the management of diabetes.
Stone, J. A., Houlden, R. L., Lin, P., Udell, J. A., Verma, S.
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.
